An Exploratory Study of Gemcitabine Hydrochloride Oral Formulation (D07001-F4) in Subjects With Malignant Tumors

NCT01678690 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

COMPLETED

Status

11

Enrollment

INDUSTRY

Sponsor class

Conditions

Malignant Tumors

Interventions

DRUG: Gemcitabine HCl Oral Formulation

Sponsor

InnoPharmax Inc.